• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化对 3T 钆塞酸二钠增强 MRI 肝增强的影响。

Impact of liver cirrhosis on liver enhancement at Gd-EOB-DTPA enhanced MRI at 3 Tesla.

机构信息

Department of Radiology, University Hospital Regensburg, Regensburg, Germany.

出版信息

Eur J Radiol. 2013 Oct;82(10):1710-5. doi: 10.1016/j.ejrad.2013.05.033. Epub 2013 Jun 25.

DOI:10.1016/j.ejrad.2013.05.033
PMID:23806531
Abstract

PURPOSE

The purpose of this study was to assess differences in enhancement effects of liver parenchyma between normal and cirrhotic livers on dynamic, Gd-EOB-DTPA enhanced MRI at 3T.

MATERIALS AND METHODS

93 patients with normal (n=54) and cirrhotic liver (n=39; Child-Pugh class A, n=18; B, n=16; C, n=5) underwent contrast-enhanced MRI with liver specific contrast media at 3T. T1-weighted volume interpolated breath hold examination (VIBE) sequences with fat suppression were acquired before contrast injection, in the arterial phase (AP), in the late arterial phase (LAP), in the portal venous phase (PVP), and in the hepatobiliary phase (HBP) after 20 min. The relative enhancement (RE) of the signal intensity of the liver parenchyma was calculated for all phases.

RESULTS

Mean RE was significantly different among all evaluated groups in the hepatobiliary phase and with increasing severity of liver cirrhosis, a decreasing, but still significant reduction of RE could be shown. Phase depending changes of RE for each group were observed. In case of non-cirrhotic liver or Child-Pugh Score A cirrhosis mean RE showed a significant increase between AP, LAP, PVP and HBP. For Child-Pugh B+C cirrhosis RE increased until PVP, however, there was no change in case of B cirrhosis (p=0.501) and significantly reduced in case of C cirrhosis (p=0.043) during HBP.

CONCLUSION

RE of liver parenchyma is negatively affected by increased severity of liver cirrhosis, therefore diagnostic value of HBP could be limited in case of Child Pugh B+C cirrhosis.

摘要

目的

本研究旨在评估正常和肝硬化肝脏在 3T 下动态、钆塞酸二钠增强 MRI 中的肝实质增强效果差异。

材料与方法

93 例患者(正常肝 54 例,肝硬化肝 39 例;Child-Pugh 分级 A 18 例,B 16 例,C 5 例)在 3T 行肝脏特异性对比剂增强 MRI。对比剂注射前、动脉期(AP)、晚期动脉期(LAP)、门静脉期(PVP)和 20 分钟后肝胆期(HBP)采集抑脂 T1 加权容积内插呼吸门控检查(VIBE)序列。计算所有相位肝实质信号强度的相对增强(RE)。

结果

在肝胆期,各组间的平均 RE 存在显著差异,且随着肝硬化严重程度的增加,RE 逐渐降低,但仍有显著差异。观察到各亚组间的相位依赖的 RE 变化。在非肝硬化或 Child-Pugh 评分 A 级肝硬化患者中,AP、LAP、PVP 和 HBP 之间的平均 RE 呈显著增加。对于 Child-Pugh B+C 肝硬化,RE 在 PVP 时增加,但在 B 级肝硬化时没有变化(p=0.501),在 C 级肝硬化时显著降低(p=0.043)。

结论

肝硬化严重程度增加会对肝实质的 RE 产生负面影响,因此在 Child-Pugh B+C 肝硬化的情况下,HBP 的诊断价值可能受到限制。

相似文献

1
Impact of liver cirrhosis on liver enhancement at Gd-EOB-DTPA enhanced MRI at 3 Tesla.肝硬化对 3T 钆塞酸二钠增强 MRI 肝增强的影响。
Eur J Radiol. 2013 Oct;82(10):1710-5. doi: 10.1016/j.ejrad.2013.05.033. Epub 2013 Jun 25.
2
Gd-EOB-DTPA-enhanced MR imaging: evaluation of hepatic enhancement effects in normal and cirrhotic livers.钆塞酸二钠增强磁共振成像:评估正常和肝硬化肝脏的肝增强效果。
Eur J Radiol. 2011 Dec;80(3):e311-6. doi: 10.1016/j.ejrad.2011.01.020. Epub 2011 Feb 18.
3
Multivariable analysis of clinical influence factors on liver enhancement of Gd-EOB-DTPA-enhanced 3T MRI.钆塞酸二钠增强3T磁共振成像肝脏强化临床影响因素的多变量分析
Rofo. 2015 Jan;187(1):29-35. doi: 10.1055/s-0034-1385211. Epub 2014 Dec 22.
4
Hepatic parenchymal enhancement at Gd-EOB-DTPA-enhanced MR imaging: correlation with morphological grading of severity in cirrhosis and chronic hepatitis.钆塞酸二钠增强磁共振成像时的肝实质增强:与肝硬化和慢性肝炎严重程度的形态学分级的相关性。
Magn Reson Imaging. 2012 Apr;30(3):356-60. doi: 10.1016/j.mri.2011.11.002. Epub 2012 Jan 5.
5
Gd-EOB-DTPA enhanced MR imaging: evaluation of biliary and renal excretion in normal and cirrhotic livers.钆塞酸二钠增强磁共振成像:正常和肝硬化肝脏的胆道和肾脏排泄评估。
Eur J Radiol. 2011 Dec;80(3):e207-11. doi: 10.1016/j.ejrad.2010.08.033. Epub 2010 Sep 24.
6
Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents.原发性硬化性胆管炎患者的磁共振胆胰管成像:与细胞外钆基对比剂相比,肝特异性对比剂延迟相 MR 图像上局灶融合性纤维化为反转表现。
Acad Radiol. 2011 Dec;18(12):1549-54. doi: 10.1016/j.acra.2011.08.007. Epub 2011 Sep 29.
7
Focal fat deposition at liver MRI with gadobenate dimeglumine and gadoxetic acid: Quantitative and qualitative analysis.肝脏 MRI 钆贝葡胺与钆塞酸二钠的局灶性脂肪沉积:定量与定性分析。
Magn Reson Imaging. 2013 Jul;31(6):911-7. doi: 10.1016/j.mri.2013.02.002. Epub 2013 Apr 15.
8
Assessing liver function using dynamic Gd-EOB-DTPA-enhanced MRI with a standard 5-phase imaging protocol.使用标准的 5 期成像方案的钆塞酸二钠增强 MRI 进行肝功能评估。
J Magn Reson Imaging. 2013 May;37(5):1109-14. doi: 10.1002/jmri.23907. Epub 2012 Oct 19.
9
Which is the best MRI marker of malignancy for atypical cirrhotic nodules: hypointensity in hepatobiliary phase alone or combined with other features? Classification after Gd-EOB-DTPA administration.哪种 MRI 标志物最能用于诊断非典型性肝硬化结节的恶性程度:单独肝胆期低信号,还是与其他特征相结合?钆塞酸二钠增强后分类。
J Magn Reson Imaging. 2012 Sep;36(3):648-57. doi: 10.1002/jmri.23685. Epub 2012 May 16.
10
Liver function correlates with liver-to-portal vein contrast ratio during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MR at 3 Tesla.在 3.0T 场强下,钆塞酸二钠增强磁共振肝胆期,肝脏功能与肝门静脉对比率相关。
Abdom Radiol (NY). 2018 Sep;43(9):2262-2269. doi: 10.1007/s00261-018-1462-y.

引用本文的文献

1
Functional Liver Imaging Score to Predict Clinically Significant PHLF for Hepatocellular Carcinoma After Resection.预测肝细胞癌切除术后临床显著肝衰竭的功能性肝脏成像评分
J Hepatocell Carcinoma. 2025 Jul 18;12:1483-1493. doi: 10.2147/JHC.S511240. eCollection 2025.
2
Occult liver nodules: their detection and characterization with CEUS.隐匿性肝结节:对比增强超声对其的检测与特征分析
Abdom Radiol (NY). 2025 Jan 18. doi: 10.1007/s00261-024-04651-8.
3
Influence of Gd-EOB-DTPA on proton-density fat fraction in the liver using chemical shift-encoded magnetic resonance imaging at 3-T.
在 3T 场强下应用化学位移编码磁共振成像技术测量 Gd-EOB-DTPA 对肝脏质子密度脂肪分数的影响。
Radiol Phys Technol. 2024 Sep;17(3):637-644. doi: 10.1007/s12194-024-00811-z. Epub 2024 May 10.
4
Relative enhancement index can be used to quantify liver function in cirrhotic patients that undergo gadoxetic acid-enhanced MRI.相对增强指数可用于量化行钆塞酸增强 MRI 的肝硬化患者的肝功能。
Eur Radiol. 2023 Jul;33(7):5142-5149. doi: 10.1007/s00330-023-09402-9. Epub 2023 Jan 18.
5
T1 reduction rate with Gd-EOB-DTPA determines liver function on both 1.5 T and 3 T MRI.使用钆塞酸二钠(Gd-EOB-DTPA)时的T1缩短率可通过1.5T和3T磁共振成像(MRI)来判定肝功能。
Sci Rep. 2022 Mar 18;12(1):4716. doi: 10.1038/s41598-022-08659-2.
6
Prediction of insufficient hepatic enhancement during the Hepatobiliary phase of Gd-EOB DTPA-enhanced MRI using machine learning classifier and feature selection algorithms.使用机器学习分类器和特征选择算法预测 Gd-EOB-DTPA 增强 MRI 肝胆期肝增强不足。
Abdom Radiol (NY). 2022 Jan;47(1):161-173. doi: 10.1007/s00261-021-03308-0. Epub 2021 Oct 13.
7
Structure guided deformable image registration for treatment planning CT and post stereotactic body radiation therapy (SBRT) Primovist (Gd-EOB-DTPA) enhanced MRI.基于结构的形变图像配准技术在治疗计划 CT 及立体定向体部放射治疗(SBRT)后钆塞酸二钠(Gd-EOB-DTPA)增强 MRI 中的应用。
J Appl Clin Med Phys. 2019 Dec;20(12):109-118. doi: 10.1002/acm2.12773. Epub 2019 Nov 22.
8
Comparison between dynamic gadoxetate-enhanced MRI and Tc-mebrofenin hepatobiliary scintigraphy with SPECT for quantitative assessment of liver function.动态钆塞酸增强 MRI 与 Tc-美罗芬酸肝胆闪烁成像 SPECT 定量评估肝功能的比较。
Eur Radiol. 2019 Sep;29(9):5063-5072. doi: 10.1007/s00330-019-06029-7. Epub 2019 Feb 22.
9
Diagnostic performance of Gd-EOB-DTPA-enhanced MRI for evaluation of liver dysfunction: a multivariable analysis of 3T MRI sequences.钆塞酸二钠增强MRI评估肝功能障碍的诊断效能:3T MRI序列的多变量分析
Oncotarget. 2018 Nov 20;9(91):36371-36378. doi: 10.18632/oncotarget.26368.
10
Hepatobiliary phase in cirrhotic patients with different Model for End-stage Liver Disease score: comparison of the performance of gadoxetic acid to gadobenate dimeglumine.肝硬化患者不同终末期肝病模型评分的肝胆期:钆塞酸二钠与钆贝葡胺的性能比较。
Eur Radiol. 2019 Jun;29(6):3090-3099. doi: 10.1007/s00330-018-5884-2. Epub 2018 Dec 13.